geneMAP™ MTB Detection Kit (MTB-RT100)
Tuberculosis (TB) remains a major public health problem worldwide. In 2015, 10.4 million new cases of TB were reported.
geneMAP™ BCR-ABL1 (p190, p210, p230) Screening Kit (BCRSCR-RT48)
BCR-ABL1 translocation can be observed in myeloproliferative neoplasms, acute leukemia of ambiguous lineage and precursor lymphoid neoplasms class as chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
geneMAP™ HLA-B*27 Detection Kit (B27-RT50)
HLA-B molecules are cell surface proteins that play an important role in immunity. The frequency of the HLA-B27 variant is about 8% in the general Caucasian population, whereas it is found in over 90% of patients suffering from ankylosing spondylitis (AS).
geneMAP™ JAK2 V617F Mutation Detection Kit (JK14-RT50)
Somatic mutation of the JAK2 gene (JAK2 p.V617F) can be detected in a variable proportion of patients with myeloproliferative neoplasms.
geneMAP™ MTB/NTM Detection Kit (MTBN-RT100)
Tuberculosis (TB) remains a major public health problem worldwide. In 2015, 10.4 million new cases of TB were reported.
geneMAP™ HLA-B*51 Detection Kit (B51-RT50)
It was diagnosed in 1937 by Hulusi Behçet, a Turkish doctor, and is therefore referred to as Behçet’s Disease or Behçet’s Syndrome in the international literature.
geneMAP™ Celiac (DQ2, DQ8, DR4) Detection Kit (CEL-RT25)
Celiac disease is a common, familial, autoimmune gastrointestinal disease. It is caused by sensitivity to the dietary protein gluten, which is present in wheat, rye, and barley.
geneMAP™ Influenza A/B Detection Kit (INFA/B-RT50)
Influenza virus infection is a highly contagious respiratory disease that can spread easily and that is responsible for considerable morbidity and mortality each year.
geneMAP™ MPL W515A/L/K/R Mutation Detection Kit (MPL-RT25)
Myeloproliferative Leukemia Virus (MPL) appears distinctly associated with polycythemia vera (PV), essential thrombocythemia (ET) and Primary myelofibrosis (PMF).
GeneMAP™ MTB/MDR Detection Kit (MDR-RT50)
Drug-resistant tuberculosis is a global health problem that hinders the progress of tuberculosis eradication programs.